Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to announce the expansion of its management team.
Dr. Scot Harper – Senior Vice President (SVP) of Clinical Operations
Dr. Harper joined RAD’s management team on 1 December 2021 as Senior Vice President (SVP) of Clinical Operations. Dr. Harper has spent his entire professional career in drug development, having held positions of progressively increasing responsibility at the VP level with companies including Eli Lilly, Novartis, and Parexel. He was also the SVP of Clinical Development at Endocyte, working on radiopharmaceutical imaging and therapies.
For more information, download the attached PDF.
Download this document
